Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020-Reference-Cited by-同舟云学术

Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020

Published:2021-10-27 Issue:10 Volume:4 Page:e2131744
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Das Satya¹,Du Liping²,Lee Cody L.¹,Arhin Nina D.¹,Chan Jennifer A.³,Kohn Elise C.⁴,Halperin Daniel M.⁵,Berlin Jordan¹,LaFerriere Heather⁶,Singh Simron⁷,Kunz Pamela L.⁸,Dasari Arvind⁵

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee

3. Dana Faber Cancer Center, Boston, Massachusetts

4. National Cancer Institute, Bethesda, Maryland

5. Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

6. Biomedical Library, Vanderbilt University, Nashville, Tennessee

7. Sunybrook Health Sciences Centre, Toronto, Canada

8. Yale Cancer Center, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2785532/das_2021_oi_210907_1634737264.71022.pdf

Reference15 articles.

1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States.;Dasari;JAMA Oncol,2017

2. Quality of clinical trials in gastroenteropancreatic neuroendocrine tumours.;Walter;Neuroendocrinology,2012

3. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.;Rindi;Mod Pathol,2018

4. The 2019 WHO classification of tumours of the digestive system.;Nagtegaal;Histopathology,2020

5. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.;Raymond;N Engl J Med,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapy for Pancreatic Neuroendocrine Tumors;Clinical Colorectal Cancer;2023-03

2. Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades;Endocrine Connections;2023-02-01

3. Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC);Cancers;2022-05-30

4. Advances in Targeted Therapy for Patients with Neuroendocrine Tumours;Oncology & Haematology;2022